Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy.
Authors: Sunde PT, Olsen I, Enersen M, Grinde B
It has been suggested that the presence of Epstein-Barr virus (EBV) can increase the severity of marginal periodontitis. We administered antiviral treatment (Valtrex((R)) for a period of 10 days) to a patient with recurrent periodontal disease and a high EBV load subgingivally. The antiviral treatment decreased the presence of EBV to the detection limit and the periodontal condition improved dramatically. One year after treatment, the periodontal condition was still stable and the virus barely detectable. The case suggests that virus screening and subsequent antiviral therapy may be useful as an adjunct to conventional periodontal therapy.
PMID: 18304869 [PubMed - as supplied by publisher] (Source: Journal of Clinical Virology)
NHS must be 'bullish' on the valuation of branded drugs
The NHS must stand its ground over what it is willing to pay for new medicines and ensure 'rigorous' assessment of value, a health economist has warned. (Source: Healthcare Republic News)
